Kiniksa Pharma Files 2025 Proxy Statement
Ticker: KNSA · Form: DEF 14A · Filed: Apr 21, 2025 · CIK: 1730430
| Field | Detail |
|---|---|
| Company | Kiniksa Pharmaceuticals International, PLC (KNSA) |
| Form Type | DEF 14A |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Kiniksa proxy filed, annual meeting June 3rd. Vote your shares!
AI Summary
Kiniksa Pharmaceuticals International, plc filed its definitive proxy statement (DEF 14A) on April 21, 2025, for its annual meeting on June 3, 2025. The filing concerns the company's governance and shareholder matters, with no specific financial transactions or executive compensation details immediately apparent from this initial review.
Why It Matters
This filing provides shareholders with crucial information regarding upcoming votes on company leadership and governance, allowing them to make informed decisions at the annual meeting.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Kiniksa Pharmaceuticals International, plc (company) — Registrant
- 20250421 (date) — Filing Date
- 20250603 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
This DEF 14A filing is a definitive proxy statement filed by Kiniksa Pharmaceuticals International, plc for its annual meeting of shareholders.
When was this filing submitted to the SEC?
The filing was submitted on April 21, 2025.
When is the scheduled date for Kiniksa's annual meeting?
The annual meeting is scheduled for June 3, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The SIC code for Kiniksa Pharmaceuticals International, plc is 2834, which corresponds to Pharmaceutical Preparations.
Where is Kiniksa Pharmaceuticals International, plc headquartered?
The company's business and mailing address is listed as 23 Old Bond Street, Floor 3, London, WIS 4PZ.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding Kiniksa Pharmaceuticals International, plc (KNSA).